Colorectal cancer: from prevention to personalized medicine.
about
Discovery and validation of new potential biomarkers for early detection of colon cancerColorectal cancer development and advances in screeningFecal DNA testing for colorectal cancer screening: Molecular targets and perspectivesColorectal cancer screening: tests, strategies, and perspectivesCurrent noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening testsAltered protein expression pattern in colon tissue of mice upon supplementation with distinct selenium compounds.Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature.Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levelsThe interaction between the Wnt/β-catenin signaling cascade and PKG activation in cancer.Index-based dietary patterns and colorectal cancer risk: a systematic review.Angiopoietin and vascular endothelial growth factor expression in colorectal disease models.Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and ChemotherapyClinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis.Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT).Krill oil extract suppresses cell growth and induces apoptosis of human colorectal cancer cells.Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database.The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironmentAbsence of the Epithelial Glycocalyx As Potential Tumor Marker for the Early Detection of Colorectal CancerA Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and SurvivalMeta-analysis of diffusion-weighted magnetic resonance imaging in identification of colorectal cancer.Promoter hypermethylation and downregulation of the FAS gene may be involved in colorectal carcinogenesisIdentification of familial colorectal cancer and hereditary colorectal cancer syndromes through the Dutch population-screening program: results ofa pilot studyA pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer.Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colonExamination of Physicians' Perception of the Indications of Colorectal Stents in the Management of Malignant Large Bowel Obstruction: A Provincial Survey.The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.Tissue-Associated Bacterial Alterations in Rectal Carcinoma Patients Revealed by 16S rRNA Community Profiling.Cost-effectiveness analysis in the Spanish setting of the PEAK trial of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancer.KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma.Postoperative changes in high mobility group box 1 levels after colorectal cancer surgery.Case-control study of candidate gene methylation and adenomatous polyp formation.Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy.Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study.Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients.Expression of the apoptosis repressor with caspase recruitment domain (ARC) in liver metastasis of colorectal cancer and its correlation with DNA mismatch repair proteins and p53.Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression.Expression of ERCC1, RRM1, TUBB3 in correlation with apoptosis repressor ARC, DNA mismatch repair proteins and p53 in liver metastasis of colorectal cancer.Bioengineered Submucosal Organoids for In Vitro Modeling of Colorectal Cancer.Therapeutic strategies against cancer stem cells in human colorectal cancer.
P2860
Q21131953-047A59F7-941E-4591-84D5-65F00BE7F0FEQ26739885-E7AEA16C-47BF-4FD4-B3AB-B0A9EA383BD0Q26781466-2714E70F-B0FE-46EE-A462-2E2CB6C3C923Q26858827-3FE1F329-A69B-46AF-A975-414A0B2F6D46Q28079672-335E0431-9B0A-4E74-9292-3D4B512EA3F6Q30313250-649A0055-0657-40D5-8AF3-B830852EB1F7Q30365404-8B8705BB-1974-4708-ABA7-C120D75E6608Q33560085-AB2C9F2D-F61F-4096-BFE8-57405B9D95E1Q33576659-B9A656AE-9871-4FC9-972B-6FC44E8C1F7FQ33768672-56587371-EA60-4402-B2DE-F29E9F1C6ABFQ34501731-159B4988-CBF1-4289-AF9F-1A7521AC590DQ35152318-D13E836B-F4FA-4A59-979B-B4A20FC1D1C1Q35647187-308D6D1F-1EC6-490B-90C0-D5FBD0107E44Q35941788-00687903-9B44-4ABB-B7D4-5C50311E47CAQ36101033-8A84AB9D-05DE-4319-8676-CDBF1E09E35CQ36117370-FE41AAB7-2620-4F93-9A8D-C793B4065886Q36128136-540E882A-A9C5-4059-9F97-70DFCD289501Q36192061-E66468BF-31A6-4666-A833-3B4079800F53Q36235592-E9AACF5F-EAE0-4A5E-A59F-85A2B42A7A25Q36294953-8CBD7FFB-3685-4DA5-BA58-6110B083C216Q36411491-EAAC8A96-FCAD-4318-91D0-2D16ADC1517DQ37000981-73919243-887D-4C3A-AFCB-286812E7AD0DQ37125187-AD0859DB-9F0F-4F5F-852F-A7CD361D0A90Q37174910-253F469C-31F1-4CD6-B184-CE47717532E0Q37269345-9546DB51-CD75-4D9B-9019-F027CDAB30FBQ37306763-B196813E-ADB4-4BC7-815A-4AB6A909B0D2Q37362510-BB59C844-CE3E-4047-91C1-EC12F616F79FQ37486656-1E91EB56-71C0-4FAD-A528-2DF240B2FEDDQ39010073-A7A331DD-FE98-4B98-977F-382C67857302Q39078976-894B417A-BC16-42CD-8C15-0180E33E72F5Q39196658-FBC57A8C-C56C-4F7D-BB87-471B1DB4ABFFQ39258008-074D680B-3FA9-41C9-8830-105E666AE723Q39339912-A12F1740-52FC-4BA4-9CDA-EBD7D5C46567Q39454229-4A85AEAE-9406-4500-86FA-4E316C982CCEQ39553253-541CDD73-6F23-4E01-9398-5A6C5328B0F8Q40154448-959FD89D-0BB1-496C-9D13-197F7987F1DAQ41334598-95D76B9B-6F9C-4C7F-AA80-537D617E74BEQ42084826-084AFA98-F96B-4AED-A4E3-49AB3E50F5C4Q45067666-F4AD59CE-CFB8-455C-8713-23D7C137AB67Q47149854-4B4F9211-D973-4D82-8787-88F00DFB2703
P2860
Colorectal cancer: from prevention to personalized medicine.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Colorectal cancer: from prevention to personalized medicine.
@ast
Colorectal cancer: from prevention to personalized medicine.
@en
type
label
Colorectal cancer: from prevention to personalized medicine.
@ast
Colorectal cancer: from prevention to personalized medicine.
@en
prefLabel
Colorectal cancer: from prevention to personalized medicine.
@ast
Colorectal cancer: from prevention to personalized medicine.
@en
P2860
P356
P1476
Colorectal cancer: from prevention to personalized medicine
@en
P2093
Alex Teule
Manuel Medina-Hayas
P2860
P304
P356
10.3748/WJG.V20.I22.6786
P407
P577
2014-06-01T00:00:00Z